文献速递新生儿儿童神经与发育行为儿童内分泌与遗传代谢

治疗性低温期间新生儿缺氧缺血性脑病的脑葡萄糖浓度

Cerebral Glucose Concentration in Neonatal Hypoxic-Ischemic Encephalopathy during Therapeutic Hypothermia.
PubMed 文献 · J Pediatr · 2023-06-14

该观察性研究对54例接受治疗性低温的脑病新生儿用磁共振波谱定量脑葡萄糖,并与扫描时平均血糖比较。治疗性低温期间脑葡萄糖显著高于复温后(65.9±22.9 vs 60.0±25.2 mg/dL,P<.01),且脑葡萄糖与血糖在基底节、丘脑、皮质灰质和白质均显著相关(r=0.39-0.42,均P<.01)。脑葡萄糖浓度与脑损伤严重程度或模式无显著差异。

要点

  • 治疗性低温期间脑葡萄糖浓度部分取决于血糖浓度。
  • 脑葡萄糖与血糖在基底节、丘脑、皮质灰质和白质均显著相关。
  • 脑葡萄糖浓度与脑损伤严重程度或模式无显著差异。

核心结论

  • 治疗性低温期间脑葡萄糖浓度部分依赖于血糖浓度,且低温期间脑葡萄糖显著高于复温后。
  • 脑葡萄糖浓度与脑损伤严重程度或模式无显著差异。

研究设计与样本

  • 观察性研究,纳入54例接受治疗性低温的脑病婴儿(30例女性,平均胎龄38.6±1.9周)。
  • 用磁共振波谱定量治疗性低温期间的脑葡萄糖,并与扫描时平均血糖比较,同时收集可能影响葡萄糖利用的临床数据。
  • 由神经放射科医生对磁共振成像上的脑损伤严重程度和模式进行评分,采用Student t检验、Pearson相关、重复测量ANOVA和多元回归分析。

主要发现

  • 41例为正常-轻度损伤,13例为中-重度损伤。
  • 治疗性低温期间葡萄糖输注速率中位数为6.0 mg/kg/min(IQR 5-7),血糖中位数为90 mg/dL(IQR 80-102)。
  • 葡萄糖输注速率与血糖或脑葡萄糖均不相关。
  • 治疗性低温期间脑葡萄糖显著高于低温后(65.9±22.9 vs 60.0±25.2 mg/dL,P<.01)。

临床怎么用

  • 接受治疗性低温的脑病新生儿中,脑葡萄糖浓度部分反映血糖水平,监测血糖可能有助于间接评估脑葡萄糖供应。
  • 葡萄糖输注速率与脑葡萄糖不相关,提示单纯调整输注速率未必能直接改变脑葡萄糖浓度。
  • 脑葡萄糖浓度与脑损伤严重程度无关,不能以脑葡萄糖水平判断损伤严重性。

局限性

  • 原文为观察性研究,未报告样本量以外的混杂控制细节。
  • 原文未报告脑葡萄糖与长期神经发育结局的关系。
  • 原文未报告不同损伤模式亚组的脑葡萄糖具体数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine cerebral glucose concentration and its relationship with glucose infusion rate (GIR) and blood glucose concentration in neonatal encephalopathy during therapeutic hypothermia (TH). METHODS: This was an observational study in which cerebral glucose during TH was quantified by magnetic resonance (MR) spectroscopy and compared with mean blood glucose at the time of scan. Clinical data (gestational age, birth weight, GIR, sedative use) that could affect glucose use were collected. The severity and pattern of brain injury on MR imaging were scored by a neuroradiologist. Student t test, Pearson correlation, repeated measures ANOVA, and multiple regression analysis were performed. RESULTS: Three-hundred-sixty blood glucose values and 402 MR spectra from 54 infants (30 female infants; mean gestational age 38.6 ± 1.9 weeks) were analyzed. In total, 41 infants had normal-mild and 13 had moderate-severe injury. Median GIR and blood glucose during TH were 6.0 mg/kg/min (IQR 5-7) and 90 mg/dL (IQR 80-102), respectively. GIR did not correlate with blood or cerebral glucose. Cerebral glucose was significantly greater during than after TH (65.9 ± 22.9 vs 60.0 ± 25.2 mg/dL, P < .01), and there was a significant correlation between blood glucose and cerebral glucose during TH (basal ganglia: r = 0.42, thalamus: r = 0.42, cortical gray matter: r = 0.39, white matter: r = 0.39, all P < .01). There was no significant difference in cerebral glucose concentration in relation to injury severity or pattern. CONCLUSIONS: During TH, cerebral glucose concentration is partly dependent on blood glucose concentration. Further studies to understand brain glucose use and optimal glucose concentrations during hypothermic neuroprotection are needed.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Tetarbe M, Wisnowski JL, Geyer E, et al. Cerebral Glucose Concentration in Neonatal Hypoxic-Ischemic Encephalopathy during Therapeutic Hypothermia. J Pediatr. 2023. PMID: 37321289. doi:10.1016/j.jpeds.2023.113560

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。